We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+2.68%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$37.9B
AUM Growth
-$464M
Cap. Flow
-$1.14B
Cap. Flow %
-3.01%
Top 10 Hldgs %
41.6%
Holding
747
New
101
Increased
198
Reduced
342
Closed
84

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$145M
2
IBM icon
IBM
IBM
+$127M
3
QCOM icon
Qualcomm
QCOM
+$103M
4
RTX icon
RTX Corp
RTX
+$73.1M
5
UNH icon
UnitedHealth
UNH
+$70.4M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$295M
2
HPQ icon
HP
HPQ
+$248M
3
CSCO icon
Cisco
CSCO
+$204M
4
JNJ icon
Johnson & Johnson
JNJ
+$176M
5
TGT icon
Target
TGT
+$165M

Sector Composition

Rank Sector Weight
1 Healthcare 24.59%
2 Consumer Staples 23.17%
3 Technology 21.44%
4 Communication Services 7.02%
5 Energy 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$1.84B 4.85%
55,295,985
-1,166,137
-2% -$38.4M
JNJ icon
2
Johnson & Johnson
JNJ
$624B
$1.84B 4.85%
21,210,245
-1,961,446
-8% -$176M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$3.89T
$1.81B 4.77%
83,009,619
-4,587,611
-5% -$101M
ORCL icon
4
Oracle
ORCL
$346B
$1.64B 4.32%
49,441,971
-397,249
-0.8% -$12.9M
KO icon
5
Coca-Cola
KO
$349B
$1.53B 4.03%
40,398,770
-1,689,544
-4% -$66.8M
PG icon
6
Procter & Gamble
PG
$342B
$1.47B 3.87%
19,414,973
+559,978
+3% +$44.6M
CVX icon
7
Chevron
CVX
$387B
$1.47B 3.87%
12,072,776
+36,633
+0.3% +$4.5M
IBM icon
8
IBM
IBM
$195B
$1.41B 3.73%
7,982,881
+701,234
+10% +$127M
PM icon
9
Philip Morris
PM
$298B
$1.4B 3.7%
16,210,217
+353,042
+2% +$30.9M
PFE icon
10
Pfizer
PFE
$143B
$1.37B 3.61%
50,303,321
-10,852,602
-18% -$295M
WMT icon
11
Walmart Inc
WMT
$863B
$1.13B 2.99%
46,011,222
-916,587
-2% -$23.1M
PEP icon
12
PepsiCo
PEP
$184B
$1.08B 2.84%
13,553,502
-1,176,362
-8% -$96.7M
CSCO icon
13
Cisco
CSCO
$444B
$975M 2.57%
41,617,205
-8,213,314
-16% -$204M
ESRX
14
DELISTED
Express Scripts Holding Company
ESRX
$871M 2.29%
14,091,140
-1,828,767
-11% -$118M
MCD icon
15
McDonald's
MCD
$187B
$747M 1.97%
7,762,911
-10,608
-0.1% -$1.04M
CL icon
16
Colgate-Palmolive
CL
$72.1B
$657M 1.73%
11,074,436
-1,609,440
-13% -$95.4M
MRK icon
17
Merck
MRK
$322B
$633M 1.67%
13,929,081
+359,443
+3% +$16.4M
MMM icon
18
3M
MMM
$87.5B
$623M 1.64%
6,241,223
+679,284
+12% +$66M
MDT icon
19
Medtronic
MDT
$105B
$539M 1.42%
10,124,082
+480,764
+5% +$25.9M
ABT icon
20
Abbott
ABT
$175B
$532M 1.4%
16,030,229
-1,556,600
-9% -$54.6M
QCOM icon
21
Qualcomm
QCOM
$180B
$493M 1.3%
7,322,254
+1,572,341
+27% +$103M
UNH icon
22
UnitedHealth
UNH
$385B
$473M 1.25%
6,609,403
+983,995
+17% +$70.4M
AAPL icon
23
Apple
AAPL
$4.72T
$470M 1.24%
27,628,692
-7,587,384
-22% -$126M
XOM icon
24
ExxonMobil
XOM
$650B
$470M 1.24%
5,459,887
-188,109
-3% -$17M
HPQ icon
25
HP
HPQ
$22.4B
$418M 1.1%
43,859,421
-22,469,036
-34% -$248M
1
2 3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2013 Portfolio in Review

As of Q3 2013, Grantham, Mayo, Van Otterloo & Co (GMO) held 747 positions worth $37.9B, down 1.2% from $38.4B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $1.14B in Q3 2013, closing 84 positions and reducing 342 holdings. Its most notable exit was SPRINT CORP FON COM, an estimated $36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Omnicom Group worth $35.3M.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q3 2013 buy was Omnicom Group: 557,023 shares worth $35.3M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Baidu in Q3 2013, an estimated $145M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q3 2013 reduction was Pfizer, cutting an estimated $295M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $36M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 42% of its $37.9B portfolio in Q3 2013.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 101 new positions and closed 84 in Q3 2013.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 1.2% quarter-over-quarter to $37.9B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2013, filed 14 Nov 2013.